Evidence map›Paper›PMID 37845609›Full record

ArticleBMC pediatrics2023

Troponin I, CK-MB, and inotropic score in hypoxic-ischemic encephalopathy and associated infant mortality.

Hayriye Gözde Kanmaz Kutman, Gülsüm Kadıoğlu Şimşek, Burak Ceran, Esra Beşer, Fuat Emre Canpolat

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Observational
  3. Article
  4. Role of Netrin-1 in staging hypoxic ischemic encephalopathy.Revista da Associacao Medica Brasileira (1992) · 2025
    Article
  5. Oxidative and Antioxidative Biomarker Profiles in Neonatal Hypoxic-Ischemic Encephalopathy: Insights for Pathophysiology and Treatment Strategies.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hayriye Gözde Kanmaz KutmanDepartment of Neonatology, University of Health Sciences, Ankara City Hospital MH5, 06800, Çankaya, Ankara, Turkey. gzdekanmaz@gmail.com.
Gülsüm Kadıoğlu ŞimşekDepartment of Neonatology, University of Health Sciences, Ankara City Hospital MH5, 06800, Çankaya, Ankara, Turkey.
Burak CeranDepartment of Neonatology, University of Health Sciences, Ankara City Hospital MH5, 06800, Çankaya, Ankara, Turkey.
Esra BeşerDepartment of Neonatology, University of Health Sciences, Ankara City Hospital MH5, 06800, Çankaya, Ankara, Turkey.
Fuat Emre CanpolatDepartment of Neonatology, University of Health Sciences, Ankara City Hospital MH5, 06800, Çankaya, Ankara, Turkey.
Sağlık Bilimleri Üniversitesi · TRÇankaya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCardiovascular dysfunction is common in hypoxic-ischemic encephalopathy (HIE), which is one of the leading causes of multi-organ failure in neonates. We aimed to assess troponin I and creatine kinase myocardial band (CK-MB) levels, inotropic score (IS) in HIE patients, and their associations with HIE staging and mortality.

methodThe medical records of all HIE infants admitted to our unit between 2016 and 2018 were retrospectively analyzed. Demographic characteristics of the infants, seizures, anticonvulsive therapies, maximum inotrope doses, and the derived IS (dopamine dose [µg/kg/min] + dobutamine dose [µg/kg/min] + 100 × epinephrine dose [µg/kg/min]) and CK-MB and troponin-I levels obtained in the first six hours of life were compared according to HIE staging. Comparisons between survivors and non-survivors were made.

resultsThe study included data from 195 patients. Twenty-five patients were classified as stage 3, 116 as stage 2, and 54 as stage 1 HIE. Median Troponin-I, CK-MB level, and IS significantly differed by HIE staging (p < 0.01). The deceased infants had significantly higher median troponin I level [0.36 (0.02-3) vs. 0.16 (0.01-1.1) ng/ml; p = 0.006], median IS [20 (5-120) vs. 5 (5-10); p < 0.001], however, CK-MB values were comparable with survivors [129 (51-300) vs. 60.7 (31-300) ng/ml; p = 0.57]. The area under the curve was 0.93 for IS and 0.81 for Troponin I to predict mortality.

conclusionTroponin I, CK-MB, and IS could be successfully used as disease severity markers in HIE furthermore, troponin I and IS, are good predictors of mortality. These results need to be confirmed with larger prospective multi-center studies.

Indexed as

Hypoxia-Ischemia, BrainTroponin IBiomarkersCreatine KinaseCreatine Kinase, MB FormHumansInfantInfant MortalityInfant, NewbornProspective StudiesRetrospective StudiesBiomarkersCreatine KinaseCreatine Kinase, MB FormTroponin IHypoxic-ischemic encephalopathyInotropic scoreMortalityTroponin I

Identifiers

PMID37845609
PMCPMC10578001
OpenAlexW4387670805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.